Invention Grant
- Patent Title: Nasal formulations of metoclopramide
-
Application No.: US16181841Application Date: 2018-11-06
-
Publication No.: US11020361B2Publication Date: 2021-06-01
- Inventor: Matthew J. D'Onofrio , David A. Gonyer , Shirish A. Shah , Stuart J. Madden
- Applicant: Evoke Pharma, Inc.
- Applicant Address: US CA Solana Beach
- Assignee: Evoke Pharma, Inc.
- Current Assignee: Evoke Pharma, Inc.
- Current Assignee Address: US CA Solana Beach
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/166
- IPC: A61K31/166 ; A61K41/10 ; A61M11/02 ; C07C237/44 ; A61K9/00 ; A61K9/08 ; A61K47/10 ; A61K47/12 ; A61M15/08
Abstract:
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
Public/Granted literature
- US20190070134A1 NASAL FORMULATIONS OF METOCLOPRAMIDE Public/Granted day:2019-03-07
Information query
